India, Nov. 30 -- In the past three years, we have witnessed the pharma giants stepping up to the occasion, by becoming innovative, agile and committing to India's health with full vigour. As 2022 draws to a close and the threat of COVID-19 ebbs, it is time to accelerate and brace for newer challenges and opportunities that the remaining decade has in offing.

The global pharma market growth trend of the last decade is expected to spill well over in the current one. By 2023, the global market size of pharmaceutical products is expected to cross over the $1 trillion mark for the first time. For India, EY-FICCI Indian Pharmaceutical Industry estimates the industry will touch $130 billion in value by the end of 2030, tripling from $41.7 bill...